Menarini Group / Stemline Therapeutics

New Capabilities

Incumbent in same indication; faces new competition

For 25 years, drug companies have tried to design medicines that destroy harmful proteins outright rather than blocking them. On May 1, the U.S. Food and Drug Administration (FDA) approved the first one.

Updated May 31